China’s pharma contractors rally as US supply chain pressures face industry resistance

Genscript posted adjusted net profit of US$62.52 million for the six months ended June 30, a 203 per cent year-on-year surge ...
ksn.com

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

GenScript now offers fast-track cGMP neoantigen peptide and peptide active pharmaceutical ingredients (API) from its new life-sciences manufacturing facility in Zhenjiang, leveraging its long history ...
NJBIZ

GenScript Biotech expands China production facility

GenScript Biotech Corp. has expanded its research capabilities overseas with a new life sciences facility in China, the Piscataway-headquartered company announced May 18. Located in the city of ...
Labroots

GenScript 2nd Annual Gene and Cell Engineering Summit

GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, leveraging ...
Benzinga.com

GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy

In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
Labroots

GenScript 3rd Annual Gene and Cell Engineering Summit

GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, leveraging ...